News | April 3, 2023

Rallybio Announces Acceptance of Abstract for RLYB212 at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH) NEW HAVEN, Conn.–(BUSINESS WIRE)–Apr. 3, 2023– Rallybio Corporation (Nasdaq: RLYB) today announced that an...

News | March 6, 2023

Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia — RLYB212 Showed Rapid Elimination of Transfused, HPA-1a Positive Platelets in HPA-1a Negative Subjects...

News | March 14, 2023

Deciphera Pharmaceuticals Announces QINLOCK® Included in NCCN Guidelines® for the Treatment of Second-Line GIST Patients and FDA Grants Breakthrough Therapy Designation for QINLOCK in Second-Line GIST Patients with Mutations in KIT Exon 11 and 17/18 – NCCN Guidelines...

News | April 17, 2023

COGENT BIOSCIENCES PRESENTS PRECLINICAL DATA AT AACR ANNUAL MEETING HIGHLIGHTING PRECISION THERAPY PIPELINE AND ANNOUNCES INITIATION OF PART 2 OF THE REGISTRATION-ENABLING APEX TRIAL WITH BEZUCLASTINIB IN ADVANCED SYSTEMIC MASTOCYTOSIS Preclinical data describes a...

News | February 27, 2023

Kalderos Introduces New Product Suite to Better Serve Manufacturers Navigating Drug Discount Programs CHICAGO, Feb. 27, 2023 /PRNewswire/ — Data infrastructure and analytics company Kalderos, creator of the world’s first Drug Discount Management platform,...

News | March 24, 2023

TigerConnectAppoints Two SaaS Leaders to Drive Product Enhancements and Revenue Growth Veteran leaders bring extensive experience to accelerate TigerConnect’s mission to optimize healthcare workflows with real-time communication and collaboration SANTA MONICA, Calif.,...